[EN] INGENOL-3-ACYLATES III AND INGENOL-3-CARBAMATES<br/>[FR] INGÉNOL-3-ACYLATES III ET INGÉNOL-3-CARBAMATES
申请人:LEO PHARMA AS
公开号:WO2012083953A1
公开(公告)日:2012-06-28
The invention relates to compounds of general formula I wherein R is heteroaryl optionally substituted by R7; or R is heterocycloalkyl or heterocycloalkenyl, optionally substituted by R8; or R is X wherein X is -NR11R12; and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use -alone or in combination with one or more other pharmaceutically active compounds- in therapy, for preventing, treating or ameliorating diseases or conditions responsive to stimulation of neutrophil oxidative burst, responsive to stimulation of keratinocyte IL-8 release or responsive to induction of necrosis.
该发明涉及一般式I的化合物,其中R为杂环芳基,可选择地由R7取代;或R为杂环烷基或杂环烯基,可选择地由R8取代;或R为X,其中X为-NR11R12;以及其在治疗中的药物可接受的盐、水合物或溶剂合物,用于单独使用或与一个或多个其他药用活性化合物结合在一起,用于预防、治疗或改善对中性粒细胞氧化爆发的刺激响应、对角质细胞IL-8释放的刺激响应或对坏死诱导的刺激响应的疾病或症状。